Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.24 (
mitogen-activated protein kinase
)
95,810
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A kinase distinct from the MEK activator Raf, termed
MEK kinase
-1 (MEKK), was originally identified by virtue of its homology to kinases involved in yeast mating signal cascades. Like Raf, MEKK is capable of activating MEK in vitro. High-level expression of MEKK in COS-7 cells or using vaccinia virus vectors also activates MEK and
MAPK
, indicating that MEKK and Raf provide alternative means of activating the
MAPK
signalling pathway. We have derived NIH3T3 cell sublines that can be induced to express active MEKK. Here we show that induction of MEKK does not result in the activation of
MAPK
, but instead stimulates the stress-activated protein kinases (SAPKs) which are identical to a Jun amino-terminal kinase. We find that MEKK regulates a new signalling cascade by phosphorylating an
SAPK
activator, SEK1 which in turn phosphorylates and activates
SAPK
.
...
PMID:Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. 799 70
The
MAP kinase
module (Raf/
MAPKKK
-MAPKK-
MAPK
) has been shown to be sequentially activated after mitogenic stimulation. Here we demonstrate, by site directed mutagenesis, that
MAPK
is able to retrophosphorylate its own activator, MAPKK, on two threonine residues Thr-292 and Thr-386 in vitro, and that these sites are also phosphorylated in vivo. A comparison of the kinetics of serum-mediated activation of a wild-type MAPKK and of a mutant unable to undergo phosphorylation by
MAPK
suggests that this retrophosphorylation may be involved in a negative feedback control of the cascade in vivo.
...
PMID:Growth factor-stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1). 801 50
Serpentine receptors coupled to the heterotrimeric G protein, Gi2, are capable of stimulating DNA synthesis in a variety of cell types. A common feature of the Gi2-coupled stimulation of DNA synthesis is the activation of the mitogen-activated protein kinases (MAPKs). The regulation of
MAPK
activation by the Gi2-coupled thrombin and acetylcholine muscarinic M2 receptors occurs by a sequential activation of a network of protein kinases. The
MAPK
kinase (MEK) which phosphorylates and activates
MAPK
is also activated by phosphorylation. MEK is phosphorylated and activated by either Raf or
MEK kinase
(
MEKK
). Thus, Raf and
MEKK
converge at MEK to regulate
MAPK
. Gi2-coupled receptors are capable of activating MEK and
MAPK
by Raf-dependent and Raf-independent mechanisms. Pertussis toxin catalyzed ADP-ribosylation of alpha i2 inhibits both the Raf-dependent and -independent pathways activated by Gi2-coupled receptors. The Raf-dependent pathway involves Ras activation, while the Raf-independent activation of MEK and
MAPK
does not involve Ras. The Raf-independent activation of MEK and
MAPK
most likely involves the activation of
MEKK
. The vertebrate
MEKK
is homologous to the Ste11 and Byr2 protein kinases in the yeast Saccharomyces cerevisiae and Schizosaccharomyces pombe, respectively. The yeast Ste11 and Byr2 protein kinases are involved in signal transduction cascades initiated by pheromone receptors having a 7 membrane spanning serpentine structure coupled to G proteins.
MEKK
appears to be conserved in the regulation of G protein-coupled signal pathways in yeast and vertebrates. Raf represents a divergence in vertebrates from the yeast pheromone-responsive protein kinase system.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:How does the G protein, Gi2, transduce mitogenic signals? 801 90
MEK-1 is a dual threonine and tyrosine recognition kinase that phosphorylates and activates
mitogen-activated protein kinase
(
MAPK
). MEK-1 is in turn activated by phosphorylation. Raf and
MAPK
/
extracellular signal-regulated kinase
kinase (MEKK) independently phosphorylate and activate MEK-1. Recombinant MEK-1 is also capable of autoactivation. Purified recombinant wild type MEK-1 and a mutant kinase inactive MEK-1 were used as substrates for MEKK, Raf, and autophosphorylation. MEK-1 phosphorylation catalyzed by Raf, MEKK, or autophosphorylation resulted in activation of MEK-1 kinase activity measured by phosphorylation of a mutant kinase inactive
MAPK
. Phosphoamino acid analysis and peptide mapping identified similar MEK-1 tryptic phosphopeptides after phosphorylation by
MEK kinase
, Raf, or MEK-1 autophosphorylation. MEK-1 is phosphorylated by
MAPK
at sites different from that for Raf and MEKK. Phosphorylation of MEK-1 by
MAPK
does not affect MEK-1 kinase activity. Several phosphorylation sites present in MEK-1 immunoprecipitated from 32P-labeled cells after stimulation with epidermal growth factor were common to the in vitro phosphorylated enzyme. The major site of
MAPK
phosphorylation in MEK-1 is threonine 292. Mutation of threonine 292 to alanine eliminates 90% of
MAPK
catalyzed phosphorylation of MEK-1 but does not influence MEK-1 activity. The results demonstrate that MEKK and Raf regulate MEK-1 activity by phosphorylation of common residues and thus, two independent protein kinases converge at MEK-1 to regulate the activity of
MAPK
.
...
PMID:MEK-1 phosphorylation by MEK kinase, Raf, and mitogen-activated protein kinase: analysis of phosphopeptides and regulation of activity. 801 5
The signal transduction kinase MEK (mitogen-activated protein (MAP) or extracellular signal-regulated (Erk) kinase)-1 is activated via phosphorylation by
MEKK
(
MEK kinase
) and raf kinases. We show here that these two kinases phosphorylate rat MEK-1 exclusively on two serine codons, Ser218 and Ser222. Phosphorylation of MEK-1 on serines 218 and 222 is both necessary and sufficient for MEK-1 to be activated and able to phosphorylate
MAP kinase
. A mutant form of MEK-1 that replaces these two codons with alanine cannot be activated, and one that substitutes glutamic acid residues in place of these 2 serines is active independent of activation by phosphorylation. These sites of activation occur in a region of MEK-1 that is similar to sites of activating phosphorylation in several other serine/threonine kinases, suggesting that this region may represent a conserved "activating domain" of many kinases.
MEKK
and raf display differences in site preference between these two codons, with
MEKK
showing preference for the amino acid at codon 218 and raf phosphorylating each residue approximately equally. This site preference might result in differences in the temporal or subsequent substrate patterns of MEK activation that result from these two activation pathways.
...
PMID:Identification of 2 serine residues of MEK-1 that are differentially phosphorylated during activation by raf and MEK kinase. 803 65
Ste5 is a Zn2+ finger-like protein thought to function before three kinases, Ste11 (a
MEKK
), Ste7 (a MEK), and Fus3 (a
MAPK
), in a conserved
MAP kinase
cascade required for mating in S. cerevisiae. Here, we present evidence that Ste5 forms a multikinase complex that joins these kinases for efficient Fus3 activation. By two-hybrid analysis, Ste11, Ste7, and Fus3 associate with different domains of Ste5, while Kss1, another
MAPK
, associates with the same domain as Fus3, thus implying that Ste5 simultaneously binds a
MEKK
, MEK, and
MAPK
. Ste5 copurifies with Ste11, Fus3, and a hypophosphorylated form of Ste7, and all four proteins cosediment in a glycerol gradient as if in a large complex. Ste5 also increases the amount of Ste11 complexed to Ste7 and Fus3 and is required for Ste11 to function. These results substantiate a novel signal transduction component that physically links multiple kinases within a single cascade.
...
PMID:Ste5 tethers multiple protein kinases in the MAP kinase cascade required for mating in S. cerevisiae. 806 90
We have investigated the early in vivo signaling events triggered by serum that lead to activation of the c-fos proto-oncogene in HeLa cells. Both RAF-1 and
MEK kinase
activities are fully induced within 3 min of serum treatment and quickly decrease thereafter, slightly preceding the activation and inactivation of p42MAPK/
ERK2
.
ERK2
activity correlates tightly with a transient phosphatase-sensitive modification of ternary complex factor (TCF), manifested by the slower electrophoretic mobility of TCF-containing protein-DNA complexes. These induced complexes in turn correlate with the activity of the c-fos, egr-1, and junB promoters. Phorbol ester treatment induces the same events but with slower and prolonged kinetics. Inhibition of serine/threonine phosphatase activities by okadaic acid treatment reverses the repression of the c-fos promoter either after induction or without induction. This corresponds to the presence of the induced complexes and of
ERK2
activity, as well as to the activation of a number of other kinases. Inhibition of tyrosine phosphatase activities by sodium vanadate treatment delays but does not block
ERK2
inactivation, TCF dephosphorylation, and c-fos repression. The tight linkage in vivo between the activity of
MAP kinase
, TCF phosphorylation, and immediate-early gene promoter activity is consistent with the notion that a stable ternary complex over the serum response element is a direct target for the
MAP kinase
signaling cascade. Furthermore, serine/threonine phosphatases are implicated in regulating the kinase cascade, as well as the state of TCF modification and c-fos promoter activity, in vivo.
...
PMID:Transient activation of RAF-1, MEK, and ERK2 coincides kinetically with ternary complex factor phosphorylation and immediate-early gene promoter activity in vivo. 806 54
Mitogen-activated protein kinases (MAPKs) are rapidly activated in response to stimulation of diverse receptor types. MAPKs are positively regulated by phosphorylation on threonine and tyrosine by
MAP kinase
or
extracellular signal-regulated kinase
(
ERK
) kinases (MEKs).
MEK kinase
(
MEKK
) is part of a family of serine-threonine protein kinases that phosphorylate and activate MEKs independently of Raf.
MEKK
was rapidly and persistently activated in response to stimulation of resting PC12 cells with epidermal growth factor (EGF). Nerve growth factor (NGF) and 12-O-tetradecanoylphorbol-13-acetate (TPA) also activated
MEKK
, although to a lesser degree than did EGF. Activation of
MEKK
and B-Raf in response to EGF was inhibited by expression of dominant negative N17Ras. Expression of oncogenic Ras resulted in activation of
MEKK
. Stimulation of synthesis of cyclic adenosine 3',5'-monophosphate abolished activation of
MEKK
and B-Raf by EGF, NGF, and TPA. Thus, Ras simultaneously controls the activation of members of the Raf and
MEKK
families of protein kinases.
...
PMID:Ras-dependent growth factor regulation of MEK kinase in PC12 cells. 807 91
MAP (mitogen-activated protein) kinases are serine/threonine protein kinases and mediate intracellular phosphorylation events linking various extracellular signals to different cellular targets.
MAP kinase
, MAP kinase kinase and
MAP kinase kinase kinase
are functional protein kinase units that are conserved in several signal transduction pathways in animals and yeasts. Isolation of all three components was also shown in plants and suggests conservation of a protein kinase module in all eukaryotic cells. In plants,
MAP kinase
modules appear to be involved in ethylene signaling and auxin-induced cell proliferation. Therefore, coupling of different extracellular signals to different physiological responses is mediated by
MAP kinase
cascades and appears to have evolved from a single prototypical protein kinase module which has been adapted to the specific requirements of different organisms.
...
PMID:MAP kinases: universal multi-purpose signaling tools. 812 84
We have studied in cultured rat astroglial cells MAP kinases, known for their role in intracellular signal transduction. The
MAP kinase
activity was stimulated by growth factors (FGFb, FGFa, EGF, PDGF, and IGF1), by a phorbol ester (TPA) activating-protein kinase C (PKC), by a neuropeptide (endothelin-1), and by a neuromediator (carbachol). Astrocytes pretreated for 18 h with TPA were still stimulated by growth factors and endothelin, suggesting that down-regulated isoforms of PKC are not involved in
MAP kinase
activation. In contrast, the small effect of carbachol was suppressed by TPA pretreatment. Astrocytes contained two proteins (p41 and p44) recognized by
MAP kinase
antibody. These proteins were phosphorylated on tyrosine residues in the cytosols of stimulated astrocytes. The kinetics of
MAP kinase
activation by FGFb and IGF1 were very different. FGFb promoted a rapid activation of
MAP kinase
(about 10 min) plus a prolonged phase that lasted at least 12 h. IGF1 produced only a rapid transient peak of activation at about 20 min. Hence, extracellular signals might generate different effects in astrocytes by differentially modulating the
MAP kinase
cascade. On a Mono Q column the growth factor-stimulated
MAP kinase
activity was separated into two peaks containing p41 and p44. Stimulation of astrocytes altered the elution pattern of p44 as a result of its phosphorylation. An ATP-dependent
MAP kinase
activator (MW = 40-45 kDa) was found in fractions of FGFb-stimulated cells which were not retained on Mono Q column, indicating the existence of a MAP kinase kinase (MEK) in astrocytes. C-Raf, identified in other cells as a
MAP kinase kinase kinase
, was also present in astrocytes.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:MAP kinase cascade in astrocytes. 816 69
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>